Institution benchmarking
Institutions
Overall
Institution | 2018 | 2019 | 2020 | 2021 | 2022 | Present |
---|---|---|---|---|---|---|
The Thrombosis and Atherosclerosis Research Institute (TaARI), Canada | 0 | 0 | 0 | 0 | 0 | 0.18 |
Biological sciences
Institution | 2018 | 2019 | 2020 | 2021 | 2022 | Present |
---|---|---|---|---|---|---|
The Thrombosis and Atherosclerosis Research Institute (TaARI), Canada | 0 | 0 | 0 | 0 | 0 | 0.04 |
Chemistry
Institution | 2018 | 2019 | 2020 | 2021 | 2022 | Present |
---|---|---|---|---|---|---|
The Thrombosis and Atherosclerosis Research Institute (TaARI), Canada | 0 | 0 | 0 | 0 | 0 | 0 |
Earth & environmental sciences
Institution | 2018 | 2019 | 2020 | 2021 | 2022 | Present |
---|---|---|---|---|---|---|
The Thrombosis and Atherosclerosis Research Institute (TaARI), Canada | 0 | 0 | 0 | 0 | 0 | 0 |
Health sciences
Institution | 2022 | Present |
---|---|---|
The Thrombosis and Atherosclerosis Research Institute (TaARI), Canada | 0 | 0.18 |
Health sciences was added to the Nature Index in 2023 with research output data from primary research articles dating back to January 1st, 2022. View the complete list of journals in health sciences.
Physical sciences
Institution | 2018 | 2019 | 2020 | 2021 | 2022 | Present |
---|---|---|---|---|---|---|
The Thrombosis and Atherosclerosis Research Institute (TaARI), Canada | 0 | 0 | 0 | 0 | 0 | 0 |
Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Comprehensive deep-dives and custom high-quality reports
Nature Strategy Reports gives you simple insights into what matters most
The reports created for you by our subject matter experts combine compelling insights with Nature’s trust and authority. Get an in-depth analysis of your and your peers’ research performance, including a breakdown of relative strengths and weaknesses. All of which is crafted using data and tools from across Nature Research Intelligence, covering all major disciplines and all regions of the world.